Co-Authors
This is a "connection" page, showing publications co-authored by Andrew Aronsohn and Matthew Odenwald.
Connection Strength
1.220
-
Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease. Nat Microbiol. 2023 Nov; 8(11):2033-2049.
Score: 0.929
-
A Rare Case of an Aggressive Liver Tumor. Clin Gastroenterol Hepatol. 2021 07; 19(7):e72.
Score: 0.183
-
Fecal metabolite profiling identifies liver transplant recipients at risk for postoperative infection. Cell Host Microbe. 2024 Jan 10; 32(1):117-130.e4.
Score: 0.059
-
"Raising HOPE": Improved Outcomes for HIV/HCV-coinfected Liver Transplant Recipients in the Direct-acting Antiviral Era. Transplant Direct. 2021 Jul; 7(7):e707.
Score: 0.049